Renovus Capital Partners Recapitalizes ClinicalMind, LLC
November 25, 2019
Renovus Capital Partners has recapitalized ClinicalMind, LLC to support expansion of the medical communications agency and growth of its enGauge SaaS technology. The equity financing will fund expansion of ClinicalMind’s strategic and tactical agency services and its physician-engagement and medical affairs SaaS platform; Excel Partners advised the sell-side while DLA Piper and BrownRudnick served as legal counsel.
- Buyers
- Renovus Capital Partners
- Targets
- ClinicalMind, LLC
- Industry
- Healthcare Services
- Location
- New York, United States
- Transaction Type
- Recapitalization
Explore More
Related Acquisitions
-
Renovus Capital Partners Closes $325M Continuation Fund to Recapitalize Four Portfolio Companies
February 27, 2024
Professional Services
Renovus Capital Partners closed a $325 million multi-asset continuation fund to recapitalize four portfolio companies — Aretum, ClinicalMind, Lockstep Technology Group and Phoenix East Aviation — enabling existing LPs to realize gains while providing rollover capital and an incremental $60 million for strategic acquisitions. The fund was anchored by leading limited partners including New 2ND Capital, RCP Advisors, Blackstone Strategic Partners, Montana Capital Partners, Unigestion and Arcano Partners; Jefferies served as exclusive financial advisor and DLA Piper as legal counsel.
-
ClinicalMind Acquires 11TEN Innovation Partners
April 23, 2024
Healthcare Services
ClinicalMind, a healthcare marketing and communications firm based in New York, has acquired 11TEN Innovation Partners, an Atlanta-based healthcare strategy and innovation consulting firm. The acquisition combines ClinicalMind's medical communications, training, and technology capabilities with 11TEN's commercial strategy and innovation ecosystem to offer integrated end-to-end services for life sciences clients.
-
Renovus Capital Partners Forms Life Sciences Commercialization Platform by Merging MC3 and Curtis Learning
July 13, 2022
Healthcare Services
Renovus Capital Partners has created a new life sciences commercialization platform through a majority investment and merger of MC3 and Curtis Learning. The combined company brings together MC3's meeting production and virtual delivery technology with Curtis Learning's scientific training expertise to scale services for pharmaceutical and biotech clients.
-
Renovus Capital Partners Backs Combination of Clinical Care Options and Practicing Clinicians Exchange
January 17, 2019
Education
Renovus Capital Partners provided equity financing to combine Clinical Care Options (CCO) and Practicing Clinicians Exchange (PCE), two leading medical and healthcare education companies. The deal merges CCO's oncology- and specialty-focused CME/CE platform based in Reston, Virginia with PCE's NP/PA‑focused continuing education business in Greenwich, Connecticut to broaden capabilities, audience reach, and product distribution.
-
Renovus Capital Partners Makes Growth Investment in Thought Logic Consulting
February 7, 2021
Consulting
Renovus Capital Partners has made a growth capital investment in Thought Logic Consulting to support the firm's investments in its team and capabilities, accelerate planned geographic expansion, and pursue industry partnerships and acquisitions. Thought Logic, a business and technology transformation consultancy with offices in Atlanta, GA and Richmond, VA, will leverage Renovus' experience in scaling founder-led services businesses.
-
Ampersand Capital Partners Majority Recapitalizes Julius Clinical Research
November 28, 2023
Healthcare Services
Ampersand Capital Partners has completed a majority recapitalization of Julius Clinical Research, a Zeist-based clinical CRO, to support geographic expansion and deepen the company's scientific and therapeutic expertise. The investment will help Julius grow its CRO services in CNS, renal, cardiometabolic and infectious disease areas and expand its footprint in Europe and North America.
Track M&A activity that matters to you
Get real-time deal alerts, build buyer lists with AI, and access our full acquisition database. Start your free trial today.